Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00475917
Status:
TERMINATED
Last Update Posted:
2015-08-21
First Post:
2007-05-17
Brief Title:
A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies
Sponsor:
Exelixis
Organization:
Exelixis
Organization Data
Organization:
Exelixis
Class:
INDUSTRY
Study ID:
XL844-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Exelixis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None